The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Pregnant patients with T2IDs using dupilumab did not have an increased rate of adverse events when compared with patients not receiving dupilumab.

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

US President Donald Trump’s administration is putting pressure on Europe to ditch a rulebook that would compel developers of advanced artificial intelligence to follow stricter standards of ...

While the amount saved through federal lease cancellations by the Trump administration has decreased nationwide, New York's contribution has increased, even though the number of canceled leases is ...

The Trump administration reversed its abrupt termination of student visa registrations in a federal database. WASHINGTON – The Trump administration reversed course and said it is restoring the ...

Harvard University president Alan Garber said during an interview with "NBC Nightly News" anchor Lester Holt on Wednesday that he had no choice but to fight the Trump administration after Harvard ...

"The Biden Administration misled borrowers: the executive branch does not have the constitutional authority to wipe debt away, nor do the loan balances simply disappear." The Biden administration ...

During President Joe Biden’s four years in office, his administration approved roughly $600 million in grants with descriptions containing the words “men who have sex with men,” according to ...

Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for chronic spontaneous urticaria (CSU) ...

WEDNESDAY, April 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with chronic spontaneous urticaria.